AllMeD Solutions Ltd. a publicly-traded company (TASE:ALMD), is a group of companies developing advanced minimally invasive products. The company headquarter is located in Caesarea, Israel and its products are marketed world-wide. Our companies portfolio: ProCatid - Embolic Protection System for the Carotid arteries TruLeaf - Mitral valve regurgitation problem, affecting millions of people around the globe. Allevetix - developer and manufacturer of innovative minimal invasive therapy for the treatment of type 2 diabetes in obese and overweight patients.